why choose us

First received: September 12, 2023

Clinical Trial: Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route

Study Status: Completed

Recruit Status: RECRUITING

Condition: Rheumatoid Arthritis

Study Type: INTERVENTIONAL


Official Title: A Single Dose, Double-Blind, Parallel Arm, Comparative Pharmacokinetic Study of DRL_AB, US Licensed Reference Abatacept (Orencia®) and EU Approved Reference (Orencia®), Administered by the Subcutaneou

Brief Summary: This is a randomised, double-blind, single dose, parallel groups study to compare the PK, immunogenicity, and safety of 3 abatacept products (DRL_AB, RP and RMP) in male NHV.

Read more